Skip to main content

Table 1 Composition of artemether and lumefantrine loaded LSES

From: Solubility enhancing lipid-based vehicles for artemether and lumefantrine destined for the possible treatment of induced malaria and inflammation: in vitro and in vivo evaluations

i. Formulation code

A1:0.5

B1:0.5

C1:0.5

A3:1

B3:1

C3:1

O:S:C

23:51:26

16:56:28

15:57:28

23:58:29

16:63:21

11:66:23

Palm kernel oil (mg)

187.44

129.44

120.24

185.04

123.52

68.32

Solutol: Tween 80 (mg)

204.2: 204.2

223.52: 223.52

226.6: 226.6

230.6: 230.6

253.68: 253.68

274.36: 274.36

Capryol pgmc (mg)

204.16

223.52

226.56

153.76

169.12

182.96

Artemether (mg)

80

80

80

80

80

80

ii. Formulation code

A3:1

B3:1

C3:1

A3:2

A1:0.5

B1:0.5

O:S:C

32:49:19

39:45:17

24:57:19

31:41:23

30:47:23

22:52:26

Oleic acid (mg)

298.4

361.6

241

308.1

298.3

215.9

Solutol (mg)

526.4

478.8

569.25

415.14

407.8

522.7

Capryol pgmc (mg)

175.4

159.6

189.75

276.76

233.9

261.4

Lumefantrine (mg)

50

50

50

50

50

50

  1. O oil, S surfactant, C co surfactant